T. Rowe Price Associates’s MedEquities Realty Trust, Inc. MRT Stock Holding History

T. Rowe Price Associates’s Portfolio MRT Stock Details MRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-52,287	Closed	-$582K	–	2579
2019 Q1	$582K	Sell	52,287 -20,400	-28%	-$221K	﹤0.01%	2069
2018 Q4	$497K	Buy	72,687 +549	+0.8%	+$4.3K	﹤0.01%	2086
2018 Q3	$701K	Buy	72,138 +171	+0.2%	+$1.81K	﹤0.01%	2014
2018 Q2	$793K	Buy	71,967 +33,831	+89%	+$349K	﹤0.01%	1939
2018 Q1	$401K	Buy	38,136 +15,356	+67%	+$163K	﹤0.01%	2167
2017 Q4	$256K	Buy	+22,780	New	+$258K	﹤0.01%	2337

T. Rowe Price Associates's MRT Position: Q2 2019 in Review

T. Rowe Price Associates sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 52,287 shares — an estimated $582K sold.

T. Rowe Price Associates first reported a position in MRT in Q4 2017 and held it in 6 quarters. The position peaked at $793K in Q2 2018. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

T. Rowe Price Associates reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
T. Rowe Price Associates sold 52,287 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $582K.
T. Rowe Price Associates first reported a position in MedEquities Realty Trust, Inc. in Q4 2017 and held it in 6 quarters.
T. Rowe Price Associates's MedEquities Realty Trust, Inc. position peaked at $793K in Q2 2018.
0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.